An open-label phase 2a study in subjects with N-cadherin positive, advanced or recurrent solid tumors to investigate the safety and efficacy of ADH-1 administered intravenously as a single agent (Adherex protocol number AHX-01-201)
Phase of Trial: Phase II
Latest Information Update: 03 Aug 2007
At a glance
- Drugs ADH 1 (Primary)
- Indications Solid tumours
- Focus Therapeutic Use
- 03 Aug 2007 Status change from in progress to completed.
- 18 Jan 2007 Status changed from recruiting to in progress.
- 31 Oct 2005 New trial record.